Gene expression profiling elucidates a specific role for RARγ in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells

Biochemical Pharmacology

Volumn 75, Issue 5, 2008, Pages 1129-1160

  Su, Dan ^a,b   Gudas, Lorraine J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

Differentiation; Gene expression profiles; Retinoic acid receptor; Retinol; sfrp5; Tie1

Indexed keywords

CYCLOHEXIMIDE; OLIGONUCLEOTIDE; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; SECRETED FRIZZLED RELATED PROTEIN 2; TIE 1 RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; STEM CELL; TERATOCARCINOMA; WILD TYPE;

ANIMALS; CELL DIFFERENTIATION; EMBRYONAL CARCINOMA STEM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; RECEPTORS, RETINOIC ACID; TRETINOIN;

EID: 38949111026     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.11.006     Document Type: Article

References (92)

1. Hayden L.J., Hawk S.N., Sih T.R., and Satre M.A. Metabolic conversion of retinol to retinoic acid mediates the biological responsiveness of human mammary epithelial cells to retinol. J Cell Physiol 186 (2001) 437-447
2. Napoli J.L. A gene knockout corroborates the integral function of cellular retinol-binding protein in retinoid metabolism. Nutr. Rev. 58 (2000) 230-236
3. Blomhoff R., and Blomhoff H.K. Overview of retinoid metabolism and function. J Neurobiol 66 7 (2006) 606-630
4. Love J.M., and Gudas L.J. Vitamin A, differentiation and cancer. Curr Opin Cell Biol 6 (1994) 825-831
5. Altucci L., Rossin A., Raffelsberger W., Reitmair A., Chomienne C., and Gronemeyer H. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med 7 6 (2001) 680-686
6. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 10 (1996) 940-954
7. Kastner P., Mark M., and Chambon P. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?. Cell 83 (1995) 859-869
8. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., et al. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-840
9. Gudas L.J. Retinoids and vertebrate development. J Biol Chem 269 (1994) 15399-15402
10. Means A.L., and Gudas L.J. The roles of retinoids in vertebrate development. Annu Rev Biochem 64 (1995) 201-233
11. Taneja R., Bouillet P., Boylan J.F., Gaub M.P., Roy B., Gudas L.J., et al. Reexpression of retinoic acid receptor (RAR)γ or RARβ in RARγ-null F9 cells reveals a partial functional redundancy between the three RAR types. Proc Natl Acad Sci 92 (1995) 7854-7858
12. Mark M., Ghyselinck N.B., and Chambon P. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol 46 (2006) 451-480
13. Allan D., Houle M., Bouchard N., Meyer B.I., Gruss P., and Lohnes D. RARgamma and Cdx1 interactions in vertebral patterning. Dev Biol 240 1 (2001) 46-60
14. Wendling O., Ghyselinck N.B., Chambon P., and Mark M. Roles of retinoic acid receptors in early embryonic morphogenesis and hindbrain patterning. Development 128 (2001) 2031-2038
15. Ghyselinck N.B., Chapellier B., Calleja C., Kumar Indra A., Li M., Messaddeq N., et al. Genetic dissection of retinoic acid function in epidermis physiology. Ann Dermatol Venereol 129 5 Pt 2 (2002) 793-799
16. Chapellier B., Mark M., Messaddeq N., Calleja C., Warot X., Brocard J., et al. Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled. EMBO J 21 13 (2002) 3402-3413
17. Iulianella A., and Lohnes D. Chimeric analysis of retinoic acid receptor function during cardiac looping. Dev Biol 247 1 (2002) 62-75
18. McGowan S., Jackson S.K., Jenkins-Moore M., Dai H.H., Chambon P., and Snyder J.M. Mice bearing deletions of retinoic acid receptors demonstrate reduced lung elastin and alveolar numbers. Am J Respir Cell Mol Biol 23 2 (2000) 162-167
19. Purton L.E., Dworkin S., Olsen G.H., Walkley C.R., Fabb S.A., Collins S.J., et al. RARgamma is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation. J Exp Med 203 5 (2006) 1283-1293
20. Dzhagalov I., Chambon P., and He Y.W. Regulation of CD8+ T lymphocyte effector function and macrophage inflammatory cytokine production by retinoic acid receptor gamma. J Immunol 178 4 (2007) 2113-2121
21. Spanjaard R.A., Ikeda M., Lee P.J., Charpentier B., Chin W.W., and Eberlein T.J. Specific activation of retinoic acid receptors (RARs) and retinoid X receptors reveals a unique role for RARgamma in induction of differentiation and apoptosis of S91 melanoma cells. J Biol Chem 272 30 (1997) 18990-18999
22. Meister B., Fink F.M., Hittmair A., Marth C., and Widschwendter M. Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma. Anticancer Res 18 3A (1998) 1777-1786
23. Hatoum A., El-Sabban M.E., Khoury J., Yuspa S.H., and Darwiche N. Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis. Carcinogenesis 22 12 (2001) 1955-1963
24. Pettersson F., Dalgleish A.G., Bissonnette R.P., and Colston K.W. Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax. Br J Cancer 87 5 (2002) 555-561
25. Siegrist W., Hintermann E., Roggo C.N., Apfel C.M., Klaus M., and Eberle A.N. Melanoma cell growth inhibition and melanocortin receptor downregulation induced by selective and non-selective retinoids. Melanoma Res 8 2 (1998) 113-122
26. Strickland S., Smith K.K., and Marotti K.R. Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell 21 2 (1980) 347-355
27. Wang S.-Y., and Gudas L.J. Isolation of cDNA clones specific for collagen IV and laminin from mouse teratocarcinoma cells. Proc Natl Acad Sci 80 (1983) 5880-5884
28. Wang S.Y., LaRosa G.J., and Gudas L.J. Molecular cloning of gene sequences transcriptionally regulated by retinoic acid and dibutyryl cyclic AMP in cultured mouse teratocarcinoma cells. Dev Biol 107 1 (1985) 75-86
29. Hogan B.L.M., Barlow D., and Tilly R. F9 teratocarcinoma cells as a model for the differentiation of parietal and visceral endoderm in the mouse. Cancer Surv 2 (1983) 115-140
30. Boylan J.F., Lohnes D., Taneja R., Chambon P., and Gudas L.J. Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. Proc Natl Acad Sci USA 90 20 (1993) 9601-9605
31. Faria T.N., Mendelsohn C., Chambon P., and Gudas L.J. The targeted disruption of both alleles of RARbeta(2) in F9 cells results in the loss of retinoic acid-associated growth arrest. J Biol Chem 274 38 (1999) 26783-26788
32. Boylan J.F., Lufkin T., Achkar C.C., Taneja R., Chambon P., and Gudas L.J. Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol Cell Biol 15 2 (1995) 843-851
33. Zhuang Y., Faria T.N., Chambon P., and Gudas L.J. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells. Mol Cancer Res 1 8 (2003) 619-630
34. Boylan J.F., Lufkin T., Achkar C.C., Taneja R., Chambon P., and Gudas L.J. Targeted disruption of retinoic acid receptor α (RAR α) and RAR γ results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol Cell Biol 15 (1995) 843-851
35. Abu-Abed S.S., Beckett B.R., Chiba H., Chithalen J.V., Jones G., Metzger D., et al. Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor gamma and retinoid X receptor alpha. J Biol Chem 273 4 (1998) 2409-2415
36. Wu C., Khan S.A., Peng L.J., and Lange A.J. Roles for fructose-2, 6-bisphosphate in the control of fuel metabolism: beyond its allosteric effects on glycolytic and gluconeogenic enzymes. Adv Enzyme Regul 46 (2006) 72-88
37. Korhonen J., Lahtinen I., Halmekyto M., Alhonen L., Janne J., Dumont D., et al. Endothelial-specific gene expression directed by the tie gene promoter in vivo. Blood 86 5 (1995) 1828-1835
38. Puri M.C., Rossant J., Alitalo K., Bernstein A., and Partanen J. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14 23 (1995) 5884-5891
39. Eklund L., and Olsen B.R. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 312 5 (2006) 630-641
40. Liehr T., Kuhlenbaumer G., Wulf P., Taylor V., Suter U., Van Broeckhoven C., et al. Regional localization of the human epithelial membrane protein genes 1.2, and 3 (EMP1, EMP2, EMP3) to 12p12. 3, 16p13. 2, and 19q13. 3. Genomics 58 1 (1999) 106-108
41. Jones S.E., and Jomary C. Secreted frizzled-related proteins: searching for relationships and patterns. Bioessays 24 9 (2002) 811-820
42. Boulassel M.R., Tomasi J.P., Deggouj N., and Gersdorff M. COCH5B2 is a target antigen of anti-inner ear antibodies in autoimmune inner ear diseases. Otol Neurotol 22 5 (2001) 614-618
43. Robertson N.G., Skvorak A.B., Yin Y., Weremowicz S., Johnson K.R., Kovatch K.A., et al. Mapping and characterization of a novel cochlear gene in human and in mouse: a positional candidate gene for a deafness disorder, DFNA9. Genomics 46 3 (1997) 345-354
44. Robertson N.G., Lu L., Heller S., Merchant S.N., Eavey R.D., McKenna M., et al. Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic deafness with vestibular dysfunction. Nat Genet 20 3 (1998) 299-303
45. Eavey R.D., Manolis E.N., Lubianca J., Merchant S., Seidman J.G., and Seidman C. Mutations in COCH (formerly Coch5b2) cause DFNA9. Adv Otorhinolaryngol 56 (2000) 101-102
46. Wang P.J., McCarrey J.R., Yang F., and Page D.C. An abundance of X-linked genes expressed in spermatogonia. Nat Genet 27 4 (2001) 422-426
47. Hiriart E., Gruffat H., Buisson M., Mikaelian I., Keppler S., Meresse P., et al. Interaction of the Epstein-Barr virus mRNA export factor EB2 with human Spen proteins SHARP, OTT1, and a novel member of the family, OTT3, links Spen proteins with splicing regulation and mRNA export. J Biol Chem 280 44 (2005) 36935-36945
48. Hirsch D., Stahl A., and Lodish H.F. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci USA 95 15 (1998) 8625-8629
49. Raefski A.S., and O'Neill M.J. Identification of a cluster of X-linked imprinted genes in mice. Nat Genet 37 6 (2005) 620-624
50. Davies W., Isles A., Smith R., Karunadasa D., Burrmann D., Humby T., et al. Xlr3b is a new imprinted candidate for X-linked parent-of-origin effects on cognitive function in mice. Nat Genet 37 6 (2005) 625-629
51. Banerjee A., Xu H.J., Hu S.X., Araujo D., Takahashi R., Stanbridge E.J., et al. Changes in growth and tumorigenicity following reconstitution of retinoblastoma gene function in various human cancer cell types by microcell transfer of chromosome 13. Cancer Res 52 22 (1992) 6297-6304
52. Bastien J., Plassat J.L., Payrastre B., and Rochette-Egly C. The phosphoinositide 3-kinase/Akt pathway is essential for the retinoic acid-induced differentiation of F9 cells. Oncogene 25 14 (2006) 2040-2047
53. Wang L., Mear J.P., Kuan C.Y., and Colbert M.C. Retinoic acid induces CDK inhibitors and growth arrest specific (Gas) genes in neural crest cells. Dev Growth Differ 47 3 (2005) 119-130
54. Chang C.W., Tsai C.W., Wang H.F., Tsai H.C., Chen H.Y., Tsai T.F., et al. Identification of a developmentally regulated striatum-enriched zinc-finger gene, Nolz-1, in the mammalian brain. Proc Natl Acad Sci USA 101 8 (2004) 2613-2618
55. Wulf P., and Suter U. Embryonic expression of epithelial membrane protein 1 in early neurons. Brain Res Dev Brain Res 116 2 (1999) 169-180
56. Kerley J.S., Olsen S.L., Freemantle S.J., and Spinella M.J. Transcriptional activation of the nuclear receptor corepressor RIP140 by retinoic acid: a potential negative-feedback regulatory mechanism. Biochem Biophys Res Commun 285 4 (2001) 969-975
57. Scantlebury T., Sniderman A.D., and Cianflone K. Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes. Biochem J 356 Pt 2 (2001) 445-452
58. Kaneko-Ishino T., Kuroiwa Y., Miyoshi N., Kohda T., Suzuki R., Yokoyama M., et al. Peg1/Mest imprinted gene on chromosome 6 identified by cDNA subtraction hybridization. Nat Genet 11 1 (1995) 52-59
59. Reule M., Krause R., Hemberger M., and Fundele R. Analysis of Peg1/Mest imprinting in the mouse. Dev Genes Evol 208 3 (1998) 161-163
60. Ito Y. Oncogenic potential of the RUNX gene family: 'overview'. Oncogene 23 24 (2004) 4198-4208
61. de Bruijn M.F., and Speck N.A. Core-binding factors in hematopoiesis and immune function. Oncogene 23 24 (2004) 4238-4248
62. Yoshikawa M., Senzaki K., Yokomizo T., Takahashi S., Ozaki S., and Shiga T. Runx1 selectively regulates cell fate specification and axonal projections of dorsal root ganglion neurons. Dev Biol 303 2 (2007) 663-674
63. Graw J. The crystallins: genes, proteins and diseases. Biol Chem 378 11 (1997) 1331-1348
64. Graw J., Neuhauser-Klaus A., Klopp N., Selby P.B., Loster J., and Favor J. Genetic and allelic heterogeneity of Cryg mutations in eight distinct forms of dominant cataract in the mouse. Invest Ophthalmol Vis Sci 45 4 (2004) 1202-1213
65. Finley K.R., Tennessen J., and Shawlot W. The mouse secreted frizzled-related protein 5 gene is expressed in the anterior visceral endoderm and foregut endoderm during early post-implantation development. Gene Expr Patterns 3 5 (2003) 681-684
66. Kemp C., Willems E., Abdo S., Lambiv L., and Leyns L. Expression of all Wnt genes and their secreted antagonists during mouse blastocyst and postimplantation development. Dev Dyn 233 3 (2005) 1064-1075
67. Leaf I., Tennessen J., Mukhopadhyay M., Westphal H., and Shawlot W. Sfrp5 is not essential for axis formation in the mouse. Genesis 44 12 (2006) 573-578
68. Roman-Gomez J., Cordeu L., Agirre X., Jimenez-Velasco A., San Jose-Eneriz E., Garate L., et al. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood 109 8 (2007) 3462-3469
69. Nojima M., Suzuki H., Toyota M., Watanabe Y., Maruyama R., Sasaki S., et al. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene (2007)
70. Marsit C.J., McClean M.D., Furniss C.S., and Kelsey K.T. Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. Int J Cancer 119 8 (2006) 1761-1766
71. Cheah P.Y., Meng Y.B., Yang X., Kimbrell D., Ashburner M., and Chia W. The Drosophila l(2)35Ba/nocA gene encodes a putative Zn finger protein involved in the development of the embryonic brain and the adult ocellar structures. Mol Cell Biol 14 2 (1994) 1487-1499
72. Nomura M., Zou Z., Joh T., Takihara Y., Matsuda Y., and Shimada K. Genomic structures and characterization of Rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain. J Biochem (Tokyo) 120 5 (1996) 987-995
73. Cerwenka A., Bakker A.B., McClanahan T., Wagner J., Wu J., Phillips J.H., et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12 6 (2000) 721-727
74. Oppenheim D.E., Roberts S.J., Clarke S.L., Filler R., Lewis J.M., Tigelaar R.E., et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 6 9 (2005) 928-937
75. Gudas L.J., Sporn M.B., and Roberts A.B. Cellular biology and biochemistry of the retinoids. In: Sporn M.B., Roberts A.B., and Goodman D.S. (Eds). The retinoids: biology, chemistry, and medicine (1994), Raven Press, New York 443-520
76. Parrella E., Gianni M., Fratelli M., Barzago M.M., Raska Jr. I., Diomede L., et al. Antitumor activity of the retinoid-related molecules (E)-3-(4′-hydroxy-3′-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: role of retinoic acid receptor gamma and retinoid-independent pathways. Mol Pharmacol 70 3 (2006) 909-924
77. Dilworth F.J., and Chambon P. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene 20 24 (2001) 3047-3054
78. Bastien J., and Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328 (2004) 1-16
79. Hauksdóttir H., and Privalsky M.L. DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia. Cell Growth Differ 12 (2001) 85-98
80. Farboud B., Hauksdottir H., Wu Y., and Privalsky M.L. Isotype-restricted corepressor recruitment: a constitutively closed helix 12 conformation in retinoic acid receptors beta and gamma interferes with corepressor recruitment and prevents transcriptional repression. Mol Cell Biol 23 8 (2003) 2844-2858
81. Bruck N., Bastien J., Bour G., Tarrade A., Plassat J.L., Bauer A., et al. Phosphorylation of the retinoid x receptor at the omega loop, modulates the expression of retinoic-acid-target genes with a promoter context specificity. Cell Signal 17 10 (2005) 1229-1239
82. Eifert C., Sangster-Guity N., Yu L.M., Chittur S.V., Perez A.V., Tine J.A., et al. Global gene expression profiles associated with retinoic acid-induced differentiation of embryonal carcinoma cells. Mol Reprod Dev 73 7 (2006) 796-824
83. Niwa H., Miyazaki J., and Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24 4 (2000) 372-376
84. LaRosa G.J., and Gudas L.J. An early effect of retinoic acid: cloning of an mRNA (Era-1) exhibiting rapid and protein synthesis-independent induction during teratocarcinoma stem cell differentiation. Proc Natl Acad Sci USA 85 2 (1988) 329-333
85. Langston A.W., Thompson J.R., and Gudas L.J. Retinoic acid-responsive elements located 3′ of the Hox A and Hox B homeobox gene clusters: functional analysis. J Biol Chem 272 (1997) 2167-2175
86. Langston A.W., and Gudas L.J. Identification of a retinoic acid responsive enhancer 3′ of the murine homeobox gene Hox 1.6. Mech Dev 38 (1992) 217-228
87. Gillespie R.F., and Gudas L.J. Retinoic acid receptor isotype specificity in F9 teratocarcinoma stem cells results from the differential recruitment of coregulators to retinoic response elements. J Biol Chem 282 (2007) 33421-33434
88. Gillespie R.F., and Gudas L.J. Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells. J Mol Biol 372 (2007) 298-316
89. Bastien J., Adam-Stitah S., Riedl T., Egly J.M., Chambon P., and Rochette-Egly C. TFIIH interacts with the retinoic acid receptor gamma and phosphorylates its AF-1-activating domain through cdk7. J Biol Chem 275 29 (2000) 21896-21904
90. Cerignoli F., Guo X., Cardinali B., Rinaldi C., Casaletto J., Frati L., et al. retSDR1, a short-chain retinol dehydrogenase/reductase, is retinoic acid-inducible and frequently deleted in human neuroblastoma cell lines. Cancer Res 62 (2002) 1196-1204
91. Kopf E., Plassat J.L., Vivat V., de The H., Chambon P., and Rochette-Egly C. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway. J Biol Chem 275 43 (2000) 33280-33288
92. Balmer J.E., and Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res 43 (2002) 1773-1808